TrialJournal of hematology & oncology2013

Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study.

Hui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.